Disease | systemic scleroderma |
Comorbidity | |hypertension |
Sentences | 68 |
PubMedID- 21510736 | Pulmonary arterial hypertension associated with systemic sclerosis. |
PubMedID- 23547391 | There are data in the literature on the relationship of hyperuricemia with pulmonary arterial hypertension in patients with systemic sclerosis. |
PubMedID- 20808962 | Limited systemic sclerosis patients with pulmonary arterial hypertension show biomarkers of inflammation and vascular injury. |
PubMedID- 21965635 | Methods: studies using haq-di and/or sf-36 in patients with pulmonary arterial hypertension (pah) associated with systemic sclerosis (pah-ssc) were identified through a systematic literature review and assessed according to the outcome measures in rheumatology clinical trials (omeract) consensus group criteria. |
PubMedID- 25146407 | Objective: to study the clinical, cardiopulmonary functional and hemodynamic profiles of systemic sclerosis patients with pulmonary hypertension (ssc-pah) compared with those of idiopathic pulmonary hypertension (ipah). |
PubMedID- 21998119 | Objective: the objective of this report is to compare baseline, management and survival characteristics in idiopathic pulmonary arterial hypertension (ipah) with systemic sclerosis-associated pulmonary arterial hypertension (ssc-apah) using data from the prospectively enrolled pah quality enhancement research initiative. |
PubMedID- 20601197 | Pulmonary arterial hypertension in systemic sclerosis. |
PubMedID- 26401258 | All patients with pulmonary hypertension and a diagnosis of systemic sclerosis, systemic lupus erythematosus, or mixed connective tissue disease who underwent the 6mwt between august 1, 2009, and october 30, 2011, were included (n = 66). |
PubMedID- 20044465 | Pulmonary arterial hypertension in systemic sclerosis: a distinctive endotheliopathy. |
PubMedID- 23687283 | Evidence-based detection of pulmonary arterial hypertension in systemic sclerosis: the detect study. |
PubMedID- 23910607 | Pulmonary hypertension in systemic sclerosis: prevalence, incidence and predictive factors in a large multicentric italian cohort. |
PubMedID- 22130820 | Risk factors associated with pulmonary arterial hypertension in patients with systemic sclerosis and implications for screening. |
PubMedID- 21492463 | Introduction: systemic sclerosis (ssc) complicated by pulmonary arterial hypertension (pah) carries a poor prognosis, despite pulmonary vascular dilating therapy. |
PubMedID- 20810505 | Prevalence of pulmonary hypertension in systemic sclerosis in european caucasians and metaanalysis of 5 studies. |
PubMedID- 21789477 | Pulmonary arterial hypertension (pah) when associated with systemic sclerosis (ssc) (ssc-pah) is one of the leading causes of mortality and is found in 10-15% of adult patients with ssc. |
PubMedID- 21048365 | Bosentan ameliorated exercise-induced pulmonary arterial hypertension complicated with systemic sclerosis. |
PubMedID- 21047671 | Pulmonary hypertension in systemic sclerosis. |
PubMedID- 20658290 | Significance of serum uric acid in pulmonary hypertension due to systemic sclerosis: a pilot study. |
Page: 1 2